The present invention relates to compositions comprised of a peptide ligand or derivatives thereof that are capable of specific binding to the high affinity receptor-1 of vascular endothelial growth factor (VEGF) and structure similar receptors. The invention further provides a peptide ligand or derivatives thereof that are capable of inhibiting angiogenesis induced by VEGF. The present invention also provides a method for treatment or diagnosis of disease associated with angiogenesis in a patient in need of therapy comprising administering to the patient an effective amount of the pharmaceutical composition of the present invention and a pharmaceutical acceptable carrier.

 
Web www.patentalert.com

< Utilized nanotechnology apparatus using a neutral network, a solution and a connection gap

< Luminescence stabilization of anodically oxidized porous silicon layers

> Nanopowder synthesis using pulsed arc discharge and applied magnetic field

> Dendrimer fluid purification system and method

~ 00288